Safety and Efficacy Study of Duet TRS
Study Details
Study Description
Brief Summary
The objectives of this clinical trial are the overall performance and safety of the ENDO GIA Staplers with ENDO GIA SULUs with Duet TRS TM.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Duet TRS Subjects receive Duet TRS |
Device: Duet TRS
Patients will have their gastric pouch created with ENDO GIA staplers with Single Use Loading Units with Duet TRS.
|
Outcome Measures
Primary Outcome Measures
- Incidence of Adverse Events. [Day 30]
Secondary Outcome Measures
- Operating Room (OR) Time [Day 0]
OR time was captured in minutes, with time starting at the first port placement and concluding at the removal of the last port.
- Length of Hospital Stay [Day 2 (Approximately 1.5 days post randomization)]
Days spent in the hospital
- Incidence of Stapler 'Misfires' [Day 0]
The incidence of stapler misfires was captured as the number of patients with misfires. The types of misfires that were captured were less than B shaped staples, incomplete staple line and stripping of the rack teeth.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
The patient must be 18-65 years of age.
-
The patient has a BMI of 40-60 kg/m2 or 35-40 kg/m2 with comorbidities
-
The patient must be willing and able to participate in the study procedures and able to understand and sign the informed consent.
Exclusion Criteria:
-
The procedure is needed as revision bariatric surgery or the patient has had prior gastric surgery (nissen fundoplication, hiatal hernia, etc)
-
The patient is pregnant.
-
The patient has an active, or history of, infection at the operative site.
-
The patient is unable or unwilling to comply with the study requirements, follow-up schedule, or to give valid informed consent.
-
Patient has an abdominal ventral hernia
-
The patient has a history of liver disease
-
The patient has a history of drug or alcohol abuse
-
The patient has a history of venous thrombosis or pulmonary embolism
-
The patient has a history of coagulopathy
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Duke University Health System | Durham | North Carolina | United States | 27710 |
Sponsors and Collaborators
- Medtronic - MITG
Investigators
- Principal Investigator: Aurora Pryor, MD, Duke University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- AS08016
Study Results
Participant Flow
Recruitment Details | Between November 24, 2009 and March 29, 2010, a total of 29 patients were consented and screened for potential study participation at one institution (Duke University). Of the 29 eligible patients, 2 did not have surgery resulting in a total of 27 patients for the analysis. |
---|---|
Pre-assignment Detail | Subjects were evaluated for pre-operative and intra-operative eligibility criteria prior to enrollment. |
Arm/Group Title | Duet TRS |
---|---|
Arm/Group Description | Duet TRS is a staple line buttress |
Period Title: Overall Study | |
STARTED | 29 |
COMPLETED | 26 |
NOT COMPLETED | 3 |
Baseline Characteristics
Arm/Group Title | Duet TRS |
---|---|
Arm/Group Description | Subjects receive Duet TRS Duet TRS: Patients will have their gastric pouch created with ENDO GIA staplers with Single Use Loading Units with Duet TRS. |
Overall Participants | 29 |
Age (years) [Mean (Standard Deviation) ] | |
Mean (Standard Deviation) [years] |
42.2
(11.3)
|
Age (Count of Participants) | |
<=18 years |
0
0%
|
Between 18 and 65 years |
29
100%
|
>=65 years |
0
0%
|
Sex: Female, Male (Count of Participants) | |
Female |
24
82.8%
|
Male |
5
17.2%
|
Race (NIH/OMB) (Count of Participants) | |
American Indian or Alaska Native |
0
0%
|
Asian |
0
0%
|
Native Hawaiian or Other Pacific Islander |
0
0%
|
Black or African American |
9
31%
|
White |
17
58.6%
|
More than one race |
0
0%
|
Unknown or Not Reported |
3
10.3%
|
Region of Enrollment (participants) [Number] | |
United States |
29
100%
|
Outcome Measures
Title | Incidence of Adverse Events. |
---|---|
Description | |
Time Frame | Day 30 |
Outcome Measure Data
Analysis Population Description |
---|
Of the 29 eligible patients, 2 did not have surgery resulting in a total of 27 patients for the analysis. |
Arm/Group Title | Duet TRS |
---|---|
Arm/Group Description | Duet TRS is a staple line buttress |
Measure Participants | 27 |
Number [adverse events] |
6
|
Title | Operating Room (OR) Time |
---|---|
Description | OR time was captured in minutes, with time starting at the first port placement and concluding at the removal of the last port. |
Time Frame | Day 0 |
Outcome Measure Data
Analysis Population Description |
---|
Of the 29 eligible patients, 2 did not have surgery resulting in a total of 27 patients for the analysis. |
Arm/Group Title | Duet TRS |
---|---|
Arm/Group Description | Duet TRS is a staple line buttress |
Measure Participants | 27 |
Mean (Standard Deviation) [minutes] |
98
(27)
|
Title | Length of Hospital Stay |
---|---|
Description | Days spent in the hospital |
Time Frame | Day 2 (Approximately 1.5 days post randomization) |
Outcome Measure Data
Analysis Population Description |
---|
Of the 29 eligible patients, 2 did not have surgery resulting in a total of 27 patients for the analysis. |
Arm/Group Title | Duet TRS |
---|---|
Arm/Group Description | Duet TRS is a staple line buttress |
Measure Participants | 27 |
Mean (Standard Deviation) [days] |
1.5
(0.6)
|
Title | Incidence of Stapler 'Misfires' |
---|---|
Description | The incidence of stapler misfires was captured as the number of patients with misfires. The types of misfires that were captured were less than B shaped staples, incomplete staple line and stripping of the rack teeth. |
Time Frame | Day 0 |
Outcome Measure Data
Analysis Population Description |
---|
Of the 29 eligible patients, 2 did not have surgery resulting in a total of 27 patients for the analysis. |
Arm/Group Title | Duet TRS |
---|---|
Arm/Group Description | Duet TRS is a staple line buttress |
Measure Participants | 27 |
Number [participants] |
3
10.3%
|
Adverse Events
Time Frame | 1 month | |
---|---|---|
Adverse Event Reporting Description | ||
Arm/Group Title | Duet TRS | |
Arm/Group Description | Duet TRS is a staple line buttress | |
All Cause Mortality |
||
Duet TRS | ||
Affected / at Risk (%) | # Events | |
Total | / (NaN) | |
Serious Adverse Events |
||
Duet TRS | ||
Affected / at Risk (%) | # Events | |
Total | 2/27 (7.4%) | |
Gastrointestinal disorders | ||
Gastrojejunal Anatomosis Stricture | 2/27 (7.4%) | 2 |
Other (Not Including Serious) Adverse Events |
||
Duet TRS | ||
Affected / at Risk (%) | # Events | |
Total | 0/27 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Noreen Fahey, Director, Clinical Program Management |
---|---|
Organization | Covidien |
Phone | 203-821-4716 |
noreen.fahey@covidien.com |
- AS08016